Weekly Digest – January 2025 Weekly Digest – January 2025 17 Jan 2025: Datroway (Datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR+, HER2- Breast Cancer Datroway is approved by FDA for metastatic HR-positive, HER2-negative breast […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id